Published in Int J Neuropsychopharmacol on September 01, 2001
Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ (2005) 3.83
Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. CMAJ (2003) 2.18
Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: a combined MRI and SPECT study. J Neurol Neurosurg Psychiatry (2002) 1.51
Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging. Prog Neurobiol (2011) 1.08
Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS. NMR Biomed (2006) 0.99
A novel effect of rivastigmine on pre-synaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer's disease. J Neurochem (2009) 0.98
Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease. J Neural Transm (Vienna) (2005) 0.91
Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET. Psychopharmacology (Berl) (2007) 0.88
Biological markers for early detection and pharmacological treatment of Alzheimer's disease. Dialogues Clin Neurosci (2009) 0.86
Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and m30 derived from rasagiline. Exp Neurobiol (2013) 0.85
Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial. Psychopharmacology (Berl) (2006) 0.82
Mild cognitive impairment in Parkinson's disease: the challenge and the promise. Neuropsychiatr Dis Treat (2005) 0.82
Acetylcholine and memory-enhancing activity of Ficus racemosa bark. Pharmacognosy Res (2011) 0.80
Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment. Cereb Cortex (2015) 0.80
Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story. Hum Genomics (2009) 0.79
(13)C heteronuclear NMR studies of the interaction of cultured neurons and astrocytes and aluminum blockade of the preferential release of citrate from astrocytes. J Biol Inorg Chem (2007) 0.79
Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open-label pilot study. Int J Geriatr Psychiatry (2012) 0.77
Current experimental therapy for Alzheimer's disease. Curr Neuropharmacol (2007) 0.76
Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer's disease. Neuropsychiatr Dis Treat (2008) 0.76
Donepezil Enhances Frontal Functional Connectivity in Alzheimer's Disease: A Pilot Study. Dement Geriatr Cogn Dis Extra (2016) 0.75
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia. Clin Interv Aging (2017) 0.75
A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. Nucleic Acids Res (1990) 8.52
Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob Agents Chemother (1979) 5.88
Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science (1990) 5.49
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ (1999) 5.36
The Healthy Eating Index: design and applications. J Am Diet Assoc (1995) 5.19
Kinetic and catalytic mechanism of HhaI methyltransferase. J Biol Chem (1987) 4.84
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet (2000) 4.37
Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys). Proc Natl Acad Sci U S A (1986) 3.76
Sequence definition and organization of a human repeated DNA. J Mol Biol (1980) 3.66
A model for the separation of large DNA molecules by crossed field gel electrophoresis. Nucleic Acids Res (1987) 3.58
Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature (2001) 3.22
Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med (2000) 3.12
Amygdala activity at encoding correlated with long-term, free recall of emotional information. Proc Natl Acad Sci U S A (1996) 3.07
Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med (2001) 3.02
Toward a unified theory of narcosis: brain imaging evidence for a thalamocortical switch as the neurophysiologic basis of anesthetic-induced unconsciousness. Conscious Cogn (2000) 2.78
Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology (1998) 2.52
Fluoro-Gold: a new fluorescent retrograde axonal tracer with numerous unique properties. Brain Res (1986) 2.47
Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA (2001) 2.38
Eyelid anatomy revisited. Dynamic high-resolution magnetic resonance images of Whitnall's ligament and upper eyelid structures with the use of a surface coil. Arch Ophthalmol (1992) 2.33
Homology between human and simian repeated DNA. Nature (1978) 2.33
Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry (1999) 2.32
Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol (1978) 2.29
Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation (2001) 2.24
Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures. Am J Ment Retard (2001) 2.23
Complete structure of the glycosyl phosphatidylinositol membrane anchor of rat brain Thy-1 glycoprotein. Nature (1988) 2.17
Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum. J Exp Med (1985) 2.15
Creutzfeldt-Jakob disease : report of 10 cases from North India. Neurol India (2001) 2.02
Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors. Proc Natl Acad Sci U S A (1991) 2.00
Structure and physical map of 64 variable segments in the 3'0.8-megabase region of the human immunoglobulin heavy-chain locus. Nat Genet (1993) 2.00
A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease. Eur Neurol (2000) 1.98
Cerebral metabolism during propofol anesthesia in humans studied with positron emission tomography. Anesthesiology (1995) 1.97
Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase. J Biol Chem (1991) 1.90
The therapeutic design of environments for people with dementia: a review of the empirical research. Gerontologist (2000) 1.89
MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport (1998) 1.89
NMR structure and mutagenesis of the third Bir domain of the inhibitor of apoptosis protein XIAP. J Biol Chem (2000) 1.88
Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits. J Biol Chem (1996) 1.80
The mechanism of free base formation from DNA by bleomycin. A proposal based on site specific tritium release from Poly(dA.dU). J Biol Chem (1983) 1.73
Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol (1989) 1.69
Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol (1994) 1.68
Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol (1997) 1.68
Radioguided surgery for the ultrastaging of the patient with melanoma. Cancer J Sci Am (1998) 1.67
Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles. J Virol (1991) 1.67
Structure and function of neuronal nicotinic acetylcholine receptors. Prog Brain Res (1996) 1.66
Characterization of human type I and type II IMP dehydrogenases. J Biol Chem (1993) 1.65
Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal. Neuropsychopharmacology (1997) 1.63
Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA (1998) 1.62
The chaperone protein 14-3-3eta interacts with the nicotinic acetylcholine receptor alpha 4 subunit. Evidence for a dynamic role in subunit stabilization. J Biol Chem (2001) 1.58
5-Fluorocytosine in DNA is a mechanism-based inhibitor of HhaI methylase. Biochemistry (1988) 1.57
Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device. Arch Ophthalmol (1992) 1.56
Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic. J Clin Microbiol (2000) 1.53
Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol (1995) 1.49
Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery (1995) 1.49
Non-cytocidal natural variants of human immunodeficiency virus isolated from AIDS patients with neurological disorders. Lancet (1987) 1.47
Diabetes mellitus as a risk factor of liver cirrhosis in patients with chronic hepatitis B virus infection. J Clin Gastroenterol (2000) 1.47
Structure of the cell-adhesion fragment of intimin from enteropathogenic Escherichia coli. Nat Struct Biol (1999) 1.46
Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. J Comp Neurol (1978) 1.45
An unusual complication of an inferior dental nerve block: a case report. Br Dent J (2009) 1.42
Detection of serum hepatitis B, C, and D viral nucleic acids and its implications in hepatocellular carcinoma patients. J Gastroenterol (1998) 1.42
Cutaneous lymphatic drainage in patients with grossly involved nodal basins. Ann Surg Oncol (1999) 1.42
Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg (1995) 1.41
Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. Mol Pharmacol (1994) 1.39
Latex foam and staple fixation of skin grafts. Br J Oral Maxillofac Surg (1998) 1.39
The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis. Structure (1999) 1.39
A nurse rostering system using constraint programming and redundant modeling. IEEE Trans Inf Technol Biomed (1997) 1.38
A simple technique to control the hair and enhance draping for major head and neck surgery. Br J Oral Maxillofac Surg (2011) 1.38
Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells. J Biol Chem (1998) 1.38
Human immunodeficiency virus type 1 nef quasispecies in pathological tissue. J Virol (1992) 1.33
A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem (1998) 1.33
Studies on human immunodeficiency virus-induced cytopathic effects: use of human rhabdomyosarcoma (RD) cells. Arch Virol (1988) 1.33
RNA folding pathway functional intermediates: their prediction and analysis. J Mol Biol (2001) 1.31
Distribution of dynorphin and enkephalin peptides in the rat brain. J Comp Neurol (1986) 1.30
The massively parallel genetic algorithm for RNA folding: MIMD implementation and population variation. Bioinformatics (2001) 1.30
Relationship of F-actin distribution to development of polar shape in human polymorphonuclear neutrophils. J Cell Biol (1992) 1.29
Nonnucleoside inhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug. AIDS Res Hum Retroviruses (1992) 1.29
Isolation of cDNA clones using yeast artificial chromosome probes. Nucleic Acids Res (1990) 1.28
Peripapillary angiomatosis associated with cat-scratch neuroretinitis. Arch Ophthalmol (1992) 1.27
Homomers of alpha 8 and alpha 7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties. Mol Pharmacol (1994) 1.27
Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C. J Med Virol (2001) 1.26
Nephrotic syndrome in indian children. Arch Dis Child (1975) 1.25
The ascending projections of the superior colliculus in the rhesus monkey (Macaca mulatta). J Comp Neurol (1975) 1.24
Reduced risk of NSAID gastropathy (GI mucosal toxicity) with nonacetylated salicylate (salsalate): an endoscopic study. Semin Arthritis Rheum (1990) 1.24
Effects of naloxone in senile dementia: a double-blind trial. N Engl J Med (1983) 1.23
Studies of Pediatric Liver Transplantation: 2002 update. An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada. Pediatr Transplant (2004) 1.23
Functional brain imaging during anesthesia in humans: effects of halothane on global and regional cerebral glucose metabolism. Anesthesiology (1999) 1.23
Reconstruction of the 2.4 Mb human DMD-gene by homologous YAC recombination. Hum Mol Genet (1992) 1.22
Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol Pharmacol (1997) 1.21
D2 dopamine receptor polymorphism and brain regional glucose metabolism. Am J Med Genet (1997) 1.21
Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord (2002) 1.20
Topography of epitopes on a polymorphic schizont antigen of Plasmodium falciparum determined by the binding of monoclonal antibodies in a two-site radioimmunoassay. Parasite Immunol (1987) 1.19
Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma. World J Surg (2000) 1.19
Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord (1997) 1.18
Studies of Pediatric Liver Transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Pediatr Transplant (2004) 1.17
"Orphan" alpha6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor. Mol Pharmacol (1997) 1.17